CLINICAL_TRIALS
trial_result
· 2025-04-16
Clinical Trial Update: Lenvatinib and Pembrolizumab Simultaneous Combination Study [Phase 2]
Summary
Phase 2 study evaluating the combination of lenvatinib and pembrolizumab in advanced gastric cancer has completed, with results posted on 2025-04-16.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Center Hospital East | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-04-16